← Back to Search

Behavioral Intervention

Yoga for High Blood Pressure

N/A
Recruiting
Research Sponsored by Texas State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and week 4, 8, and 12 measurements
Awards & highlights

Study Summary

This trial will study how yoga and deep breathing may help lower blood pressure and improve vascular function by reducing oxidative stress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and week 4, 8, and 12 measurements
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and week 4, 8, and 12 measurements for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in peripheral blood mononuclear cell NADPH oxidase cell NADPH oxidase enzyme activity
Change in peripheral blood mononuclear cell reactive oxygen species
Secondary outcome measures
Change in 24-hour blood pressure
Change in flow-mediated dilation
Change in microvascular endothelial function/thermal hyperemia

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Yoga postures or slow, deep breathingExperimental Treatment2 Interventions
Group II: ControlPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830

Find a Location

Who is running the clinical trial?

Texas State UniversityLead Sponsor
14 Previous Clinical Trials
1,368 Total Patients Enrolled

Media Library

Control breathing (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05158205 — N/A
High Blood Pressure Research Study Groups: Control, Yoga postures or slow, deep breathing
High Blood Pressure Clinical Trial 2023: Control breathing Highlights & Side Effects. Trial Name: NCT05158205 — N/A
Control breathing (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05158205 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How do I become involved in this research endeavor?

"Candidates for this clinical trial must be between 40 and 60 years old, and have a diagnosis of hypertension. A total of 90 participants will be enrolled in the study."

Answered by AI

Is participation in this trial available to eligible patients?

"The clinical trial is actively searching for participants, as confirmed by clinicaltrials.gov's records that date back to July 11th 2022 and have been updated up until October 25th 2022."

Answered by AI

How many participants are currently participating in this investigation?

"Affirmative, clinicaltrials.gov currently reflects that this medical trial is actively seeking participants. Having been first posted on July 11th 2022 and recently updated on October 25th 2022, the investigation requires 90 individuals at a single site."

Answered by AI

Is there an age cutoff for eligibility in this research project?

"This research is recruiting participants aged 40 to 60 years old."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Cardiovascular Physiology Laboratory-Texas State University
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Yoga in Altering Mechanistic Outcomes in Hypertension
2022. "Yoga in Altering Mechanistic Outcomes in Hypertension". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05158205.
All > Hypertension
~22 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top